Value-Based Purchasing and Comparative Effectiveness Research

Share this article:
Value-Based Purchasing and Comparative Effectiveness Research
Value-Based Purchasing and Comparative Effectiveness Research
Value-Based Purchasing and Comparative Effectiveness: Why the Pharmaceutical, Biotechnology, and Medical-Surgical Device Industries Should Embrace the Coming Market Evolution

For years, health economics has assisted healthcare stakeholders in making informed evaluations of treatment alternatives. Now, the advent of value-based purchasing (VBP) and comparative effectiveness research (CER) are leading to new methods for identifying products with the highest "value"—those that ideally deliver both overall cost reductions and improved patient health. These trends will increasingly impact the way healthcare products are marketed and sold.

This paper examines the march to VBP and CER evaluations, and makes specific recommendations to manufacturers and brand teams regarding how combining clinical and economic data is essential to the successful marketing of drugs and devices.

Please click here to download this white paper.

About MarCom Group International, Inc.:

MarCom Group International works with US and global pharmaceutical, medical-surgical, and biotechnology companies to provide medical marketing communications, health economics, and physician education services. MarCom's health economics team combines expert research, strategic analytics, and scientific communications for world-class results.

Click here for more information about MarCom Group International, Inc.





How to download the MarCom White Paper:

If you don't have a username and password to mmm-online.com,
  • Click "register here" on the MarCom White Paper download page
  • Enter in your contact information
  • An email will be sent to your email address with a link to confirm your registration
  • Click on the link in your email to sign in your username and new password
  • Download the MarCom White Paper



Share this article:
You must be a registered member of MMM to post a comment.

Email Newsletters

MM&M EBOOK: PATIENT ACCESS

Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.

More in Features

Is your marketing strategy stuck in 2005?

Is your marketing strategy stuck in 2005?

It is not enough to just have a killer black book or Rolodex. The market needs agile, swift marketing

Is guidance stifling social media?

Recent FDA draft guidance was meant to help companies create FDA-compliant tweets and handle third-party misinformation on the web. What other obstacles lie in the path of effective social media use?

FDA social media guides draw flak

FDA social media guides draw flak

Two FDA guidance documents on how health product manufacturers may participate in social media have drawn criticism from industry and consumer groups.